| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(90)91166-4 |
| P698 | PubMed publication ID | 2244566 |
| P50 | author | Jon A Kobashigawa | Q64877043 |
| P2093 | author name string | M Hamilton | |
| L W Stevenson | |||
| J Walden | |||
| J Moriguchi | |||
| J H Tillisch | |||
| M Luu | |||
| C Chelimsky-Fallick | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ejection fraction | Q641303 |
| hemodynamics | Q1642137 | ||
| P304 | page(s) | 1348-1354 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy | |
| P478 | volume | 66 |
| Q35672466 | A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure |
| Q77313227 | ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology |
| Q34981129 | Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy |
| Q49967829 | Advanced congestive heart failure |
| Q78061884 | Aggravated renal dysfunction and the acute management of advanced chronic heart failure |
| Q44011684 | Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure |
| Q36694354 | Approaches to decongestion in patients with acute decompensated heart failure |
| Q37578565 | Are scores useful in advanced heart failure? |
| Q37721628 | Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi |
| Q45072710 | Association between diuretic use, clinical response, and death in acute heart failure |
| Q35741773 | Association of impedance cardiography parameters with changes in functional and quality-of-life measures in patients with chronic heart failure |
| Q34594268 | BNP in hormone-guided treatment of heart failure |
| Q44182274 | Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol |
| Q74660344 | Beyond drug therapy: nonpharmacologic care of the patient with advanced heart failure |
| Q83429372 | Body mass index and rest myocardial perfusion defect predicts cardiac death in patients with chronic heart failure |
| Q33745166 | Bone marrow-derived cells contribute to fibrosis in the chronically failing heart |
| Q73736762 | Brain natriuretic peptide as bridge to therapy for heart failure |
| Q43755395 | Brain natriuretic peptide-guided therapy for heart failure |
| Q68035369 | Cardiac transplantation: clinical aspects of recipient selection |
| Q71514071 | Changes in left ventricular filling during follow-up study in survivors and nonsurvivors of idiopathic dilated cardiomyopathy |
| Q45303057 | Clinical and left ventricular function outcomes up to five years after dynamic cardiomyoplasty |
| Q40586285 | Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure |
| Q36836551 | Clinical findings, natriuretic peptides, and echocardiography: integrating tools to optimize heart failure management. |
| Q48170133 | Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper |
| Q35350198 | Current issues in advanced heart failure |
| Q33818330 | Current medical therapy for advanced heart failure |
| Q74660334 | Current medical therapy for advanced heart failure |
| Q71514093 | Determinants of prognosis in nonischemic dilated cardiomyopathy |
| Q85032473 | Diastolic Dysfunction in Pediatric Cardiac Patients: Evaluation and Management |
| Q63479551 | Differential Effect of Acute Baroreceptor Unloading on Cardiac and Systemic Sympathetic Tone in Congestive Heart Failure |
| Q46145731 | Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors alpha1 and beta1. |
| Q51436144 | Duration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantation. |
| Q40237273 | Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study |
| Q43796480 | Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure |
| Q54116801 | Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. |
| Q74666765 | Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy |
| Q67485411 | Estimating severity of chronic heart failure: A clinical challenge for the 1990s |
| Q61716910 | Etiology and response to drug treatment in heart failure |
| Q52053680 | Feasibility and accuracy of transthoracic Doppler echocardiographic estimation of pulmonary capillary wedge pressure applying different methods. |
| Q37411832 | Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis |
| Q41692771 | Heart failure--outlooks and strategies for treatment |
| Q30724401 | Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? |
| Q44635339 | Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure |
| Q71381979 | Impact of medical therapy on pulmonary hypertension in patients with congestive heart failure awaiting cardiac transplantation |
| Q57631087 | Improving survival for patients with atrial fibrillation and advanced heart failure |
| Q38263598 | Machines versus medication for biventricular heart failure: focus on the total artificial heart |
| Q36303919 | Management of refractory congestive heart failure |
| Q41725503 | Mechanisms of arrhythmias in heart failure |
| Q71590586 | Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure |
| Q77291896 | Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time |
| Q80888699 | Neurohormonal Therapy for Congestive Heart Failure |
| Q37590474 | Nitroprusside in decompensated heart failure: what should a clinician really know? |
| Q36922122 | Parallel improvement of left ventricular geometry and filling pressure after transcatheter aortic valve implantation in high risk aortic stenosis: comparison with major prosthetic surgery by standard echo Doppler evaluation |
| Q52238715 | Percent achieved of predicted peak exercise oxygen uptake and kinetics of recovery of oxygen uptake after exercise for risk stratification in chronic heart failure. |
| Q35860284 | Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study |
| Q78143393 | Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support |
| Q94556338 | Rapid clinical assessment of hemodynamic profiles and targeted treatment of patient with acutely decompensated heart failure |
| Q34766698 | Rationale for the short term use of intravenous milrinone under hemodynamic guidance in patients with severe systolic heart failure |
| Q38055507 | Reassessing the use of vasodilators in heart failure |
| Q57631074 | Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure |
| Q38953625 | Remote Monitoring to Reduce Heart Failure Readmissions |
| Q36303971 | Review of randomized trials of digoxin therapy in patients with chronic heart failure |
| Q36567872 | Right heart catheterization and risk stratification in advanced heart failure |
| Q33816527 | Role of inotropic agents in the treatment of heart failure. |
| Q59712598 | Role of the etiology of cardiomyopathies on exercise capacity and oxygen consumption in patients with severe congestive heart failure |
| Q35724692 | Selection of patients and techniques of heart transplantation |
| Q57003371 | Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications |
| Q46638446 | Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure |
| Q47289573 | Supplementary ultrafiltration may improve inflammation and cardiac dysfunction in patients with high interdialytic weight gain |
| Q33997965 | Tailored therapy to hemodynamic goals for advanced heart failure |
| Q73109994 | Tailored therapy using dobutamine and nitroglycerin in advanced heart failure |
| Q44790292 | Target Heart Failure Populations for Newer Therapies |
| Q36908694 | Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center |
| Q51379826 | The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study. |
| Q93910485 | The jugular veins: knowing enough to look |
| Q74660329 | The pathophysiology of advanced heart failure |
| Q35105833 | The prognostic significance of renal dysfunction in patients with chronic systolic heart failure |
| Q35162704 | The prognostic value of the physical examination in patients with chronic heart failure |
| Q43723158 | The relationship between obesity and mortality in patients with heart failure |
| Q35135789 | The role of echocardiography in the diagnosis and management of heart failure |
| Q41563106 | The unique management of refractory advanced systolic heart failure |
| Q58867581 | The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association |
| Q58867585 | The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association |
| Q38349760 | The vulnerable phase after hospitalization for heart failure |
| Q37348166 | Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure |
| Q36796946 | Therapeutic and diagnostic role of electrical devices in acute heart failure. |
| Q73716470 | Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure |
| Q39203291 | Treatment Approaches to Congestion Relief in Acute Decompensated HF: Insights After DOSE-AHF and CARRESS-HF. |
| Q48173387 | Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. |
| Q59684510 | Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure |
| Q41815113 | Utility of global strain by two-dimensional and three-dimensional speckle tracking for assessing left ventricular diastolic function: comparison with pressure wire analysis |
| Q51703737 | Validation of an echo-Doppler decision model to predict left ventricular filling pressure in patients with heart failure independently of ejection fraction. |
| Q35313284 | Vasodilators. A re-evaluation of their role in heart failure |
| Q38361005 | Walking the tightrope: Using quantitative Doppler echocardiography to optimize ventricular filling pressures in patients hospitalized for acute heart failure |
| Q42549664 | What is the prognostic significance of pulmonary hypertension in heart failure? |
| Q37379777 | Who has advanced heart failure?: definition and epidemiology |
Search more.